Venus Concept (NASDAQ:VERO) Shares Down 6.2% – Should You Sell?

Shares of Venus Concept Inc. (NASDAQ:VERO) traded down 6.2% during trading on Monday . The company traded as low as $2.55 and last traded at $2.71. 135,751 shares traded hands during mid-day trading, a decline of 64% from the average session volume of 376,090 shares. The stock had previously closed at $2.89.

Venus Concept Trading Down 6.2 %

The firm’s 50 day moving average is $3.41 and its 200 day moving average is $3.87. The company has a debt-to-equity ratio of 2.83, a current ratio of 1.86 and a quick ratio of 1.18. The company has a market cap of $3.86 million, a PE ratio of -0.34 and a beta of 0.25.

Venus Concept (NASDAQ:VERO) last released its quarterly earnings results on Monday, March 31st. The company reported ($11.23) earnings per share for the quarter, missing the consensus estimate of ($10.01) by ($1.22). The firm had revenue of $15.77 million for the quarter, compared to analysts’ expectations of $16.99 million.

About Venus Concept

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.